Cargando…

Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study

BACKGROUND: Age is the strongest risk factor for dementia and there is considerable interest in identifying scalable, blood-based biomarkers in predicting dementia. We examined the role of midlife serum metabolites using a machine learning approach and determined whether the selected metabolites imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado-Fragua, Marcos D., Landré, Benjamin, Chen, Mathilde, Fayosse, Aurore, Dugravot, Aline, Kivimaki, Mika, Sabia, Séverine, Singh-Manoux, Archana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513883/
https://www.ncbi.nlm.nih.gov/pubmed/36163029
http://dx.doi.org/10.1186/s12916-022-02519-6
_version_ 1784798163058556928
author Machado-Fragua, Marcos D.
Landré, Benjamin
Chen, Mathilde
Fayosse, Aurore
Dugravot, Aline
Kivimaki, Mika
Sabia, Séverine
Singh-Manoux, Archana
author_facet Machado-Fragua, Marcos D.
Landré, Benjamin
Chen, Mathilde
Fayosse, Aurore
Dugravot, Aline
Kivimaki, Mika
Sabia, Séverine
Singh-Manoux, Archana
author_sort Machado-Fragua, Marcos D.
collection PubMed
description BACKGROUND: Age is the strongest risk factor for dementia and there is considerable interest in identifying scalable, blood-based biomarkers in predicting dementia. We examined the role of midlife serum metabolites using a machine learning approach and determined whether the selected metabolites improved prediction accuracy beyond the effect of age. METHODS: Five thousand three hundred seventy-four participants from the Whitehall II study, mean age 55.8 (standard deviation (SD) 6.0) years in 1997–1999 when 233 metabolites were quantified using nuclear magnetic resonance metabolomics. Participants were followed for a median 21.0 (IQR 20.4, 21.7) years for clinically-diagnosed dementia (N=329). Elastic net penalized Cox regression with 100 repetitions of nested cross-validation was used to select models that improved prediction accuracy for incident dementia compared to an age-only model. Risk scores reflecting the frequency with which predictors appeared in the selected models were constructed, and their predictive accuracy was examined using Royston’s R(2), Akaike’s information criterion, sensitivity, specificity, C-statistic and calibration. RESULTS: Sixteen of the 100 models had a better c-statistic compared to an age-only model and 15 metabolites were selected at least once in all 16 models with glucose present in all models. Five risk scores, reflecting the frequency of selection of metabolites, and a 1-SD increment in all five risk scores was associated with higher dementia risk (HR between 3.13 and 3.26). Three of these, constituted of 4, 5 and 15 metabolites, had better prediction accuracy (c-statistic from 0.788 to 0.796) compared to an age-only model (c-statistic 0.780), all p<0.05. CONCLUSIONS: Although there was robust evidence for the role of glucose in dementia, metabolites measured in midlife made only a modest contribution to dementia prediction once age was taken into account. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02519-6.
format Online
Article
Text
id pubmed-9513883
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95138832022-09-28 Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study Machado-Fragua, Marcos D. Landré, Benjamin Chen, Mathilde Fayosse, Aurore Dugravot, Aline Kivimaki, Mika Sabia, Séverine Singh-Manoux, Archana BMC Med Research Article BACKGROUND: Age is the strongest risk factor for dementia and there is considerable interest in identifying scalable, blood-based biomarkers in predicting dementia. We examined the role of midlife serum metabolites using a machine learning approach and determined whether the selected metabolites improved prediction accuracy beyond the effect of age. METHODS: Five thousand three hundred seventy-four participants from the Whitehall II study, mean age 55.8 (standard deviation (SD) 6.0) years in 1997–1999 when 233 metabolites were quantified using nuclear magnetic resonance metabolomics. Participants were followed for a median 21.0 (IQR 20.4, 21.7) years for clinically-diagnosed dementia (N=329). Elastic net penalized Cox regression with 100 repetitions of nested cross-validation was used to select models that improved prediction accuracy for incident dementia compared to an age-only model. Risk scores reflecting the frequency with which predictors appeared in the selected models were constructed, and their predictive accuracy was examined using Royston’s R(2), Akaike’s information criterion, sensitivity, specificity, C-statistic and calibration. RESULTS: Sixteen of the 100 models had a better c-statistic compared to an age-only model and 15 metabolites were selected at least once in all 16 models with glucose present in all models. Five risk scores, reflecting the frequency of selection of metabolites, and a 1-SD increment in all five risk scores was associated with higher dementia risk (HR between 3.13 and 3.26). Three of these, constituted of 4, 5 and 15 metabolites, had better prediction accuracy (c-statistic from 0.788 to 0.796) compared to an age-only model (c-statistic 0.780), all p<0.05. CONCLUSIONS: Although there was robust evidence for the role of glucose in dementia, metabolites measured in midlife made only a modest contribution to dementia prediction once age was taken into account. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02519-6. BioMed Central 2022-09-27 /pmc/articles/PMC9513883/ /pubmed/36163029 http://dx.doi.org/10.1186/s12916-022-02519-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Machado-Fragua, Marcos D.
Landré, Benjamin
Chen, Mathilde
Fayosse, Aurore
Dugravot, Aline
Kivimaki, Mika
Sabia, Séverine
Singh-Manoux, Archana
Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study
title Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study
title_full Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study
title_fullStr Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study
title_full_unstemmed Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study
title_short Circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the Whitehall II cohort study
title_sort circulating serum metabolites as predictors of dementia: a machine learning approach in a 21-year follow-up of the whitehall ii cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513883/
https://www.ncbi.nlm.nih.gov/pubmed/36163029
http://dx.doi.org/10.1186/s12916-022-02519-6
work_keys_str_mv AT machadofraguamarcosd circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT landrebenjamin circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT chenmathilde circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT fayosseaurore circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT dugravotaline circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT kivimakimika circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT sabiaseverine circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy
AT singhmanouxarchana circulatingserummetabolitesaspredictorsofdementiaamachinelearningapproachina21yearfollowupofthewhitehalliicohortstudy